Thromb Haemost 2000; 83(04): 617-621
DOI: 10.1055/s-0037-1613873
Commentary
Schattauer GmbH

Identification of a Novel 33-kDa Ser/Thr Kinase that Phosphorylates the Cytoplasmic Tail of Protease-activated Receptor 1 (Thrombin Receptor) in Human Platelets

Masaru Ido
1   From the Department of Molecular Pathobiology, Mie University School of Medicine, Tsu-city, Mie, Japan
,
Tatsuya Hayashi
1   From the Department of Molecular Pathobiology, Mie University School of Medicine, Tsu-city, Mie, Japan
,
Esteban C. Gabazza
1   From the Department of Molecular Pathobiology, Mie University School of Medicine, Tsu-city, Mie, Japan
,
Koji Suzuki
1   From the Department of Molecular Pathobiology, Mie University School of Medicine, Tsu-city, Mie, Japan
› Author Affiliations
Supported in part by Grant-in-aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (Nos. 08680680, 08557064, 09480149).
Further Information

Publication History

Received 17 January 1999

Accepted after resubmission 29 November 1999

Publication Date:
08 December 2017 (online)

Summary

Stimulation of human platelets with thrombin or thrombin receptor agonist peptide (TRAP/ Ser-Phe-Leu-Leu-Arg-Asn) resulted in phosphorylation of the protease-activated receptor 1 (PAR1). However, protein kinase(s), capable of phosphorylating PAR1 upon activation of this receptor, has not been as yet identified in human platelets. The present study was undertaken to assess the presence of protein kinase(s) that may interact with PAR1 using a procedure based on the ability of protein kinase to undergo renaturation and phosphorylate a protein substrate fixed in a gel. We employed a fusion protein that was prepared using a glutathione S-transferase (GST) and the cytoplasmic tail of PAR1 (Pro368-Thr425)(GST-PAR1) or a reverse sequenced peptide of this domain (GST-rPAR1). The results showed that treatment of platelets with thrombin induced about 10-fold increase in the activity of the 33-kDa Ser/Thr protein kinase, which was also activated by TRAP, but not by hirudin-treated thrombin or diisopropylfluorophosphate-inactivated thrombin, suggesting that it is activated through PAR1. Furthermore, treatment of platelets with thromboxane A2 analog, STA2, led to an activation of this protein kinase and phosphorylation of PAR1. In conclusion, the present study provides evidence of homologous and heterologous activation of a novel 33-kDa Ser/Thr kinase that phosphorylates the cytoplasmic tail of PAR1.

 
  • References

  • 1 Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
  • 2 Rasmussen UB, Vouret CV, Jallat S, Schlesinger Y, Pages G, Pavirani A, Lecocq JP, Pouyssegur J, Van O, Schilling E. cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett 1991; 288: 123-8.
  • 3 Chen J, Ishii M, Wang L, Ishii K, Coughlin SR. Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. J Biol Chem 1994; 269: 16041-5.
  • 4 Verrall S, Ishii M, Chen M, Wang L, Tram T, Coughlin SR. The thrombin receptor second cytoplasmic loop confers coupling to Gq-like G proteins in chimeric receptors. Additional evidence for a common transmembrane signaling and G protein coupling mechanism in G protein-coupled receptors. J Biol Chem 1997; 272: 6898-902.
  • 5 Shapiro MJ, Trejo J, Zeng D, Coughlin SR. Role of the thrombin receptor’s cytoplasmic tail in intracellular trafficking. Distinct determinants for agonist-triggered versus tonic internalization and intracellular localization. J Biol Chem 1996; 271: 32874-80.
  • 6 Ishii K, Chen J, Ishii M, Koch WJ, Freedman NJ, Lefkowitz RJ, Coughlin SR. Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. J Biol Chem 1994; 269: 1125-30.
  • 7 Ogawa H, Ido M, Takeya H, Suzuki K. The thrombin receptor transmits signals through a 33-kDa protein kinase in human platelets. Biochem Biophys Res Commun 1994; 203: 907-13.
  • 8 Ido M, Kato S, Ogawa H, Hayashi K, Komada Y, Zhang XL, Sakurai M, Suzuki K. Ca2+-dependent activation of the 33-kDa protein kinase transmits thrombin receptor signals in human platelets. Thromb Haemost 1996; 76: 439-43.
  • 9 Kameshita I, Fujisawa H. A sensitive method for detection of calmodulindependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal Biochem 1989; 183: 139-43.
  • 10 Mann KG, Elion J, Butkowski RJ, Downing M, Nesheim ME. Prothrombin. Methods Enzymol 1981; 286-302.
  • 11 Komatsu Y, Misawa S, Sukesada A, Ohba Y, Hayashi H. CX-397, a novel recombinant hirudin analog having a hybrid sequence of hirudin variants-1 and -3. Biochem Biophys Res Commun 1993; 196: 773-9.
  • 12 Sato T, Fuse A, Eguchi M, Hayashi Y, Ryo R, Adachi M, Kishimoto Y, Teramura M, Mizoguchi H, Shima Y. et al. Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down’s syndrome patient with acute megakaryoblastic leukaemia. Br J Haematol 1989; 72: 184-90.
  • 13 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
  • 14 Cooper JA, Sefton BM, Hunter T. Detection and quantification of phosphotyrosine in proteins. Methods Enzymol 1983; 99: 387-402.
  • 15 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 1992; 24: 145-9.
  • 16 Vouret CV, Auberger P, Pouyssegur J, Van O, Schilling E. Distinct mechanisms regulate 5-HT2 and thrombin receptor desensitization. J Biol Chem 1995; 270: 4813-21.
  • 17 Brass LF, Molino M. Protease-activated G protein-coupled receptors on human platelets and endothelial cells. Thromb Haemost 1997; 78: 234-41.
  • 18 Lapetina EG. The signal transduction induced by thrombin in human platelets. FEBS Letters 1990; 268: 400-4.
  • 19 Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988; 334: 661-5.
  • 20 Kaibuchi K, Takai Y, Sawamura M, Hoshijima M, Fujikura T, Nishizuka Y. Synergistic functions of protein phosphorylation and calcium mobilization in platelet activation. J Biol Chem 1983; 258: 6701-4.
  • 21 Krupnick JG, Benovic JL. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 1998; 38: 289-319.
  • 22 Palczewski K. GTP-binding-protein-coupled receptor kinases – two mechanistic models. Eur J Biochem 1997; 248: 261-9.
  • 23 Benovic JL, Onorato JJ, Arriza JL, Stone WC, Lohse M, Jenkins NA, Gilbert DJ, Copeland NG, Caron MG, Lefkowitz RJ. Cloning, expression, and chromosomal localization of beta-adrenergic receptor kinase 2. A new member of the receptor kinase family. J Biol Chem 1991; 266: 14939-46.